FILTER BY

also on other fortune lists

Change the World

Courtesy of Johnson & Johnson

20

Johnson & Johnson

JNJ

U.S.

Through its Johnson & Johnson Institute, the pharma giant has trained some 250,000 health care workers in India since 1993. The curriculum includes instruction in advanced techniques such as minimally invasive surgeries. That’s a positive for patient outcomes in a country with a dearth of doctors and nurses—and a savvy strategic move, since the trainees learn to use J&J’s tech.

Looking for leads, investment insights, or competitive intelligence?

Impact Segment

Public Health/Nutrition

Sector

Health Care

Industry

Pharmaceuticals

CEO

Alex Gorsky

Employees

134,000

Company Type

Public

Revenues ($M) (Last Fiscal Year)

$76,450

Profits ($M) (Last Fiscal Year)

$1,300

Market Value ($M)

$350,314

News about Johnson & Johnson

What Pharma Giant Johnson & Johnson's CEO Has to Say About the Drug Price Debate

J&J chief Alex Gorsky had some thoughts to share at the Fortune Global Forum.

Read More →
These Are the Health Care Companies Poised for Explosive Growth

From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.

Read More →
Data Sheet—Fortune Global Forum Talks China, Drug Pricing, and Nobel Winners

This is your Data Sheet newsletter for Tuesday, October 16, 2018.

Read More →